In the published article, there was an error in Table 1 as published. The forward and reverse sequences for the rows “IL-6” and “MCP1” were incorrectly entered as “CTA GCT CAG GCT CGT CAG TTC.” The corrected Table 1 and its caption appear below.
Table 1
| Gene | Forward Seq. (5′-3′) | Reverse Seq. (5′-3′) |
|---|---|---|
| IRF7 | CAA TTC AGG GGA TCC AGT TG | AGC ATT GCT GAG GCT CAC TT |
| IFIT1 | ACC ATG GGA GAG AAT GCT GAT G | TGT GCA TCC CCA ATG GGT TC |
| STAT1 | GCG GCA TGC AAC TGG CAT ATA ACT | ATG CTT CCG TTC CCA CGT AGA CTT |
| STAT2 | TGA TCT CTA ACA GAC AGG TGG | CTG CAT TCA CTT CTA AAG ACT C |
| IFIT3 | ATC ATG ATG GAG GTC AAC CG | TTG CAC ACC CTG TCT TCC AT |
| IFNA4 | CTT TCC TCA TGA TCC TGG TAA TGA T | AAT CCA AAA TCC TTC CTG TCC TCC |
| IFNB1 | AAC TCC ACC AGC AGA CAG TG | GGT ACC TTT GCA CCC TCC AG |
| RIG-I | GAG TAC CAC TTA AAG CCA GAG | AAT CCA TTT CTT CAG AGC ATC C |
| IFIH1 | CGG AAG TTG GAG TCA AAG C | TTT GTT CAG TCT GAG TCA TGG |
| IL-10 | AGA CCA AGG TGT CTA CAA GGC | TCA TCA TGT ATG CTT CTA TGC AGT |
| IL-6 | ACA AGT CGG AGG CTT AAT TAC ACA | TTG CCA TTG CAC AAC TCT TTT C |
| MCP1 | TCA CCT GCT GCT ACT CAT TCA CCA | TAC AGC TTC TTT GGG ACA CCT GCT |
| CXCL10 | ATA ACC CCT TGG GAA GAT GGT G | CTA GCT CAG GCT CGT CAG TTC |
| GAPDH | ATT GTG TCC GTC GTG GAT CTG A | AGA TGC CTG CTT CAC CAC CTT CTT |
| STING | GCC TTC AGA GCT TGA CTC CA | GTA CAG TCT TCG GCT CCC TG |
| ND1 | CAG CCT GAC CCA TAG CCA TA | ATT CTC CTT CTG TCA GGT CGA A |
| COX1 | AGG CTT CAC CCT AGA TGA CAC | GTA GCG TCG TGG TAT TCC TGA A |
qPCR primers used in experiments.
List of forward and reverse sequences used for qPCR.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
brain injury, inflammation, STING, cGAS, innate immunity
Citation
Fritsch LE, Ju J, Basso EKG, Soliman E, Paul S, Chen J, Kaloss AM, Kowalski EA, Tuhy TC, Somaiya RD, Wang X, Allen IC, Theus MH and Pickrell AM (2022) Corrigendum: Type I Interferon Response Is Mediated by NLRX1-cGAS-STING Signaling in Brain Injury. Front. Mol. Neurosci. 15:965564. doi: 10.3389/fnmol.2022.965564
Received
09 June 2022
Accepted
10 June 2022
Published
29 June 2022
Volume
15 - 2022
Edited and reviewed by
Andrei Surguchov, University of Kansas Medical Center, United States
Updates
Copyright
© 2022 Fritsch, Ju, Basso, Soliman, Paul, Chen, Kaloss, Kowalski, Tuhy, Somaiya, Wang, Allen, Theus and Pickrell.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Alicia M. Pickrell alicia.pickrell@vt.eduMichelle H. Theus mtheus@vt.edu
†Present address: Jiang Chen, Sorrento Therapeutics, Inc., San Diego, CA, United States
This article was submitted to Brain Disease Mechanisms, a section of the journal Frontiers in Molecular Neuroscience
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.